BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34285329)

  • 21. The BRPF1 bromodomain is a molecular reader of di-acetyllysine.
    Obi JO; Lubula MY; Cornilescu G; Henrickson A; McGuire K; Evans CM; Phillips M; Boyson SP; Demeler B; Markley JL; Glass KC
    Curr Res Struct Biol; 2020; 2():104-115. PubMed ID: 33554132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chromatin regulator Brpf1 regulates embryo development and cell proliferation.
    You L; Yan K; Zou J; Zhao H; Bertos NR; Park M; Wang E; Yang XJ
    J Biol Chem; 2015 May; 290(18):11349-64. PubMed ID: 25773539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition of unmodified histone H3 by the first PHD finger of bromodomain-PHD finger protein 2 provides insights into the regulation of histone acetyltransferases monocytic leukemic zinc-finger protein (MOZ) and MOZ-related factor (MORF).
    Qin S; Jin L; Zhang J; Liu L; Ji P; Wu M; Wu J; Shi Y
    J Biol Chem; 2011 Oct; 286(42):36944-55. PubMed ID: 21880731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery, optimization and evaluation of 1-(indolin-1-yl)ethan-1-ones as novel selective TRIM24/BRPF1 bromodomain inhibitors.
    Xiang Q; Luo G; Zhang C; Hu Q; Wang C; Wu T; Xu H; Hu J; Zhuang X; Zhang M; Wu S; Xu J; Zhang Y; Liu J; Xu Y
    Eur J Med Chem; 2022 Jun; 236():114311. PubMed ID: 35385803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
    Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
    Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bivalent interaction of the PZP domain of BRPF1 with the nucleosome impacts chromatin dynamics and acetylation.
    Klein BJ; Muthurajan UM; Lalonde ME; Gibson MD; Andrews FH; Hepler M; Machida S; Yan K; Kurumizaka H; Poirier MG; Côté J; Luger K; Kutateladze TG
    Nucleic Acids Res; 2016 Jan; 44(1):472-84. PubMed ID: 26626149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
    Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
    Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease.
    Yang XJ
    Biochim Biophys Acta; 2015 Aug; 1853(8):1818-26. PubMed ID: 25920810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1.
    Ghazy E; Zeyen P; Herp D; Hügle M; Schmidtkunz K; Erdmann F; Robaa D; Schmidt M; Morales ER; Romier C; Günther S; Jung M; Sippl W
    Eur J Med Chem; 2020 Aug; 200():112338. PubMed ID: 32497960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic reader BRD4 inhibition as a therapeutic strategy to suppress E2F2-cell cycle regulation circuit in liver cancer.
    Hong SH; Eun JW; Choi SK; Shen Q; Choi WS; Han JW; Nam SW; You JS
    Oncotarget; 2016 May; 7(22):32628-40. PubMed ID: 27081696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lysine acetyltransferase activator Brpf1 governs dentate gyrus development through neural stem cells and progenitors.
    You L; Yan K; Zou J; Zhao H; Bertos NR; Park M; Wang E; Yang XJ
    PLoS Genet; 2015 Mar; 11(3):e1005034. PubMed ID: 25757017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in Histone Acetylase Modifier BRPF1 Cause an Autosomal-Dominant Form of Intellectual Disability with Associated Ptosis.
    Mattioli F; Schaefer E; Magee A; Mark P; Mancini GM; Dieterich K; Von Allmen G; Alders M; Coutton C; van Slegtenhorst M; Vieville G; Engelen M; Cobben JM; Juusola J; Pujol A; Mandel JL; Piton A
    Am J Hum Genet; 2017 Jan; 100(1):105-116. PubMed ID: 27939639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MOZ-BRPF1 acetyltransferase complex in epigenetic crosstalk linked to gene regulation, development, and human diseases.
    Viita T; Côté J
    Front Cell Dev Biol; 2022; 10():1115903. PubMed ID: 36712963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
    Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
    J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pygo2 activates BRPF1 via Pygo2-H3K4me2/3 interaction to maintain malignant progression in colon cancer.
    Ling J; Tang Z; Yang W; Li Y; Dong X
    Exp Cell Res; 2023 Oct; 431(1):113696. PubMed ID: 37423512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRPF1 is essential for development of fetal hematopoietic stem cells.
    You L; Li L; Zou J; Yan K; Belle J; Nijnik A; Wang E; Yang XJ
    J Clin Invest; 2016 Sep; 126(9):3247-62. PubMed ID: 27500495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aberrant Super-Enhancer Landscape in Human Hepatocellular Carcinoma.
    Tsang FH; Law CT; Tang TC; Cheng CL; Chin DW; Tam WV; Wei L; Wong CC; Ng IO; Wong CM
    Hepatology; 2019 Jun; 69(6):2502-2517. PubMed ID: 30723918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lnc-PDZD7 contributes to stemness properties and chemosensitivity in hepatocellular carcinoma through EZH2-mediated ATOH8 transcriptional repression.
    Zhang Y; Tang B; Song J; Yu S; Li Y; Su H; He S
    J Exp Clin Cancer Res; 2019 Feb; 38(1):92. PubMed ID: 30786928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.
    Zhang T; Wan C; Shi W; Xu J; Fan H; Zhang S; Lin Z; Ni R; Zhang X
    J Mol Histol; 2015 Dec; 46(6):485-97. PubMed ID: 26438629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.